1-3 of 3
Jochen Utikal
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Myeloid Cells and Related Chronic Inflammatory Factors as Novel Predictive Markers in Melanoma Treatment with Ipilimumab

Christoffer Gebhardt, Alexandra Sevko, Huanhuan Jiang, Ramtin Lichtenberger, Maike Reith, Kathrin Tarnanidis, Tim Holland-Letz, Ludmila Umansky, Philipp Beckhove, Antje Sucker, Dirk Schadendorf, Jochen Utikal, Viktor Umansky
Journal: Clinical Cancer Research
Clin Cancer Res (2015) 21 (24): 5453–5459.
https://doi.org/10.1158/1078-0432.CCR-15-0676
Published: 14 December 2015
View article titled, Myeloid Cells and Related Chronic Inflammatory Factors as Novel Predictive Markers in Melanoma Treatment with Ipilimumab
Open the PDF for Myeloid Cells and Related Chronic Inflammatory Factors as Novel Predictive Markers in Melanoma Treatment with Ipilimumab in another window
Includes: Supplementary data
Journal Articles

Efficacy of Vemurafenib in a Trametinib-Resistant Stage IV Melanoma Patient—Letter

Mathias Bernhardt, Elias Orouji, Lionel Larribere, Christoffer Gebhardt, Jochen Utikal
Journal: Clinical Cancer Research
Clin Cancer Res (2014) 20 (9): 2498–2499.
https://doi.org/10.1158/1078-0432.CCR-13-2349
Published: 30 April 2014
View article titled, Efficacy of Vemurafenib in a Trametinib-Resistant Stage IV Melanoma Patient—Letter
Open the PDF for Efficacy of Vemurafenib in a Trametinib-Resistant Stage IV Melanoma Patient—Letter in another window
Journal Articles

Neoadjuvant Imatinib in Advanced Primary or Locally Recurrent Dermatofibrosarcoma Protuberans: A Multicenter Phase II DeCOG Trial with Long-term Follow-up

Selma Ugurel, Thomas Mentzel, Jochen Utikal, Peter Helmbold, Peter Mohr, Claudia Pföhler, Meinhard Schiller, Axel Hauschild, Rüdiger Hein, Eckhardt Kämpgen, Ivonne Kellner, Martin Leverkus, Jürgen C. Becker, Philip Ströbel, Dirk Schadendorf
Journal: Clinical Cancer Research
Clin Cancer Res (2014) 20 (2): 499–510.
https://doi.org/10.1158/1078-0432.CCR-13-1411
Published: 16 January 2014
View article titled, Neoadjuvant Imatinib in Advanced Primary or Locally Recurrent Dermatofibrosarcoma Protuberans: A Multicenter Phase II DeCOG Trial with Long-term Follow-up
Open the PDF for Neoadjuvant Imatinib in Advanced Primary or Locally Recurrent Dermatofibrosarcoma Protuberans: A Multicenter Phase II DeCOG Trial with Long-term Follow-up in another window
Includes: Supplementary data